NL-OMON56573尚未招募不适用
Resect SAFE study: providing a reliable impression of the positive surgical margin in patients undergoing robot assisted radical prostatectomy for prostate cancer - Resect SAFE study
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Undergoing a non-nerve-sparing robot assisted laparoscopic radical
- •prostatectomy (unilateral or bilateral non-nerve-sparing).
- •Any value of prostate-specific antigen (PSA).
- •Any grade from the International Society of Urological Pathology (ISUP).
- •Any tumor (T) stage on the magnetic resonance imaging (MRI) scan.
排除标准
- •Molecular Imaging (MI), specifically on PSMA-PET, a lymph node (N) stage 1
- •Salvage prostatectomy
- •NeuroSAFE procedure.
研究者
相似试验
进行中（未招募）
1 期
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial)Staphylococcus aureus bacteremiaCTIS2024-515398-90-01Stichting Amsterdam UMC300
招募中
不适用
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StagePACTR201704002215604DNDi174
招募中
3 期
A confirmatory study of TRM-270 in comparison with Seprafilm in patients with rectal cancer receiving surgeryRectal cancerJPRN-jRCT2032220451Tomita Shinpei260
已完成
不适用
Safety analysis of anti-retroviral drug: Biktarvy for Japanese elderly patients.HIV-1 infectionJPRN-UMIN000041113ational Center for Global Health and Medicine10
进行中（未招募）
不适用
CLINICAL STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND IMMUNOGENICITY OF WILATE IN CHILDREN < 6 YEARS OF AGE WITH INHERITED VON WILLEBRAND DISEASEInherited von Willebrand DiseaseMedDRA version: 8.0Level: PTClassification code 10047715EUCTR2005-001426-84-CZOctapharma AG20